Navigation Links
Cord Blood America, Inc. Announces 2009 First Quarter Results
Date:5/21/2009

whose samples were stored during the year.

"During the first quarter, we took significant initiatives to position the Company for growth," said Matthew Schissler, Founder and CEO. "We shifted our business focus to capitalize on the opportunities in the processing of umbilical cord blood, deemphasizing the advertising business, as reflected by our improved gross margin. We believe that the new administration will further support growth in the stem cell industry, and in our business of collecting and storing umbilical cord blood lifting the current ban on Federal funding for research on embryonic stem cell lines. The funding should accelerate the use of stem cells in treating diabetes, heart disease, and other major diseases, driving consumers to make the investments in storage and collection."

"We also strengthened our balance sheet, reducing indebtedness, extending maturities and regaining compliance with all of our key lenders," continued Schissler. "We believe with our improved financial condition that Cord Blood America is now well-positioned to consolidate the industry as well as to acquire or build its own state-of-the-art laboratory for the storage of multiple stem cell products including umbilical cord blood stem cells, which should further improve gross margin and profitability. We believe that the Company is well positioned to play a key role as stem cell therapies become a viable treatment modality."

Conference Call:

The Company will hold a conference call at 11 a.m. eastern time today to discuss the results and outlook for the balance of the year. Interested parties may access the call by dialing 877-627-6555 (domestically) or 719-325-4931 (internationally) and referencing passcode 3112433. There will also be a replay of the call available for five days at the conclusion of the call. Parties desiring to listen to the replay may dial 888-203-1112 (domestically
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Research points to a new way to protect kidneys threatened by insufficient blood or toxins
2. Cord Blood America CEO Matthew Schissler Expands on Thought Process in Owning Stem Cell Laboratory
3. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
4. Viral Infection Might Trigger High Blood Pressure
5. Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory
6. New research confirms milestone study on blood pressure meds
7. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
8. Study finds iron levels not predictive of survival for form of blood cancer
9. Genes Yield Clues to High Blood Pressure
10. Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study
11. Too-Low Blood Pressure Can Also Bring Danger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... release is available in German . ... important intracellular signaling molecules, but their mode of action ... of cellular function and behavior, while at high concentrations ... and DNA. To analyze how redox signaling unfolds in ... microscopy technique has been developed jointly by the teams ...
(Date:4/22/2014)... help rein in massive health care spending, a new ... find ways to incentivize pharmaceutical companies and device makers ... of examining existing medical technologies and their use, a ... what drugs and medical devices get created in the ... care spending with as little loss of health as ...
(Date:4/22/2014)... all seem to know who we say is neurotic and ... unable to act but simply doesn,t want to., ... of nearly 4,000 college students in 19 countries has uncovered ... and moving forward with life. Turns out that when they ... don,t like it as much as non-neurotics. Therefore persuasive communications ...
(Date:4/22/2014)... demonstrated the first size-based form of chromatography that ... living cells. This unique physical approach to probing ... whether a cell lives or dies, remains normal ... conventional microscopy. , "We,ve developed membrane-embedded nanodot array ... probe and manipulate membrane assemblies, including signaling clusters, ...
(Date:4/22/2014)... release is available in German . ... Laboratories of the University of Vienna and the Medical University ... now shown how double stranded RNA, such as viral genetic ... During the immune response against viral infection, the protein ADAR1 ... it modifies viral RNA to inhibit reproduction of the virus. ...
Breaking Medicine News(10 mins):Health News:Neuroimaging: Live from inside the cell 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:Neurotics don't just avoid action: They dislike it 2Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3
... known to be harmful. Some of them like malaria can ... make the host female less fertile. A recent study has ... The vivacious Wolbachia is actually giving the host a boost ... ,This new study reveals the Symbiotic or mutually ...
... of the transgender community in India is highly aware of ... a survey by a Chennai-based NGO. ,"Most ... transmitted diseases and AIDS. As much as 99 percent said ... said they used condoms during sexual activity," said R. Isabel, ...
... help cut back on how much food and calories you eat ... show that when participants in the study ate a first course ... intake at lunch by 20 percent, compared to when they did ... studies about consuming lower-calorie soup as a way to reduce food ...
... are no more likely than other children to have ... ,Researchers compared blood samples of 34 children with autism ... been referred to an outpatient clinic of the same ... detect celiac diseaseanti-gliadin antibodies and anti-endomysial antibodies. Biopsies of ...
... improve symptoms of moderate to severe chronic obstructive pulmonary ... ,The results of the randomized, double-blind, ... issue of the May American Journal of Respiratory and ... ,According to an editorial commenting on the ...
... A study finds that sleep deprivation can adversely affect ... the expectation of gains and making light of ... understand the neural underpinnings of risky decision making under ... Duke University studied healthy volunteers as they underwent functional ...
Cached Medicine News:Health News:Useful Parasites 2Health News:Awareness About HIV/AIDS is High Among the Transgenders: Survey 2Health News:Taking Low-calorie Soup Before Meal Will Help Cut Calories at Meals 2Health News:Anti-inflammatory Drug Fails to Improve COPD Symptoms 2Health News:Sleep Deprivation can Affect Competent Decision-making 2
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness & ... Center by the Medical Fitness Association, a non-profit organization ... their full potential. The Cadence Fitness & Health Center ... suburbs and second in the Chicagoland area. ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... Calif., Oct. 27 ... beamforming technology, analog-front-end semiconductors and solutions for the ... Ultrasound Beamforming Development Kit.  Based on Samplify,s AutoFocus™ ... solution for the ultrasound front end, from probe ...
... Oct. 27 Solos Endoscopy, Inc. (Pink Sheets: ... revenues during the three months ended September 30, 2010 in ... ended September 30, 2009.  This was an increase of 34.8% for ... Despite a down global economy, Solos has been able ...
Cached Medicine Technology:Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 2Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 3Solos Endoscopy, Inc. Revenue Grows 34.8% for Third Quarter 2010 2
... System is designed to help physicians provide ... leg. Endovenous laser therapy is a patient-friendly ... of varicose veins., In endovenous laser therapy, ... the varicosed vein, generally through a small ...
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
... #1 physician choice in laser treatment, brings ... superficial vein reflux. EVLT is a minimally ... stripping that effectively and safely treats varicose ... occlude the vein. The procedure is easy ...
Medicine Products: